Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA

Approved

STANDARD

RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA

Viiv Healthcare B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 25, 2021
Approval ID: 7bb5220cbbc4ce03
Company: Viiv Healthcare B.V.
Type: Standard

Approval Details

Approval Id: 7bb5220cbbc4ce03
Drug Cima Aemps Name: RUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number: 1201518001
Holder Company Name: Viiv Healthcare B.V.
Marketing Company Name: Laboratorios Viiv Healthcare S.L.
Holder Company Detail Path: /organization/viiv-healthcare-bv
Authorization Date: 2021-02-25
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 600 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Viiv Healthcare B.V.
Company Detail Path: /organization/viiv-healthcare-bv

Company Information

Pharmaceutical Company Name: ViiV Healthcare BV
Country Name: Netherlands
Website: http://viivhealthcare.com/nl-nl

Active Ingredients

FOSTEMSAVIR TROMETAMOL

724,56 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 25, 2021

Approval ID

7bb5220cbbc4ce03

Type

Standard

Back to CIMA-AEMPS Approvals